Quantitative clinical proteomic study of autopsied human infarcted brain specimens to elucidate the deregulated pathways in ischemic stroke pathology

Journal of Proteomics

Volumn 91, Issue , 2013, Pages 556-568

  Datta, Arnab ^a   Akatsu, Hiroyasu ^b   Heese, Klaus ^c   Sze, Siu Kwan ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c Hanyang University   (South Korea)

Author keywords

8 Plex iTRAQ; Clinical proteomics; Ferritin; Ischemic stroke; Malate aspartate shuttle

Indexed keywords

COPROPORPHYRIN; FERRITIN; PROTOPORPHYRIN; PYRUVATE DEHYDROGENASE COMPLEX; REACTIVE OXYGEN METABOLITE;

AGED; ARTICLE; AUTOPSY; BIOINFORMATICS; BRAIN INFARCTION; BRAIN ISCHEMIA; CASE REPORT; CELL ENERGY; CITRIC ACID CYCLE; CONTROLLED STUDY; CYTOPLASM; CYTOSOL; DOWN REGULATION; ENERGY METABOLISM; FEMALE; GLYCOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYDROPHILIC INTERACTION CHROMATOGRAPHY; IMMUNOCHEMISTRY; IRON METABOLISM; JAPANESE; MITOCHONDRIAL GENOME; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NUCLEOTIDE SEQUENCE; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PARIETAL LOBE; PRIORITY JOURNAL; PROTEOMICS; PUTAMEN; QUANTITATIVE STUDY; TANDEM MASS SPECTROMETRY; THALAMUS;

8-PLEX ITRAQ; CLINICAL PROTEOMICS; FERRITIN; ISCHEMIC STROKE; MALATE-ASPARTATE SHUTTLE;

ASPARTIC ACID; AUTOPSY; BIOLOGICAL MARKERS; BRAIN; BRAIN INFARCTION; BRAIN ISCHEMIA; CLUSTER ANALYSIS; CYTOSOL; FEMALE; FERRITINS; GLIOSIS; HUMANS; IRON; MALATES; MITOCHONDRIA; NEURONS; OXYGEN; PROTEOME; PROTEOMICS; STATIC ELECTRICITY; TRYPSIN;

EID: 84884368222     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.08.017     Document Type: Article

References (47)

1. Iadecola C., Anrather J. Stroke research at a crossroad: asking the brain for directions. Nat Neurosci 2011, 14:1363-1368.
2. Lo E.H., Dalkara T., Moskowitz M.A. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 2003, 4:399-415.
3. Garland P., Broom L.J., Quraishe S., Dalton P.D., Skipp P., Newman T.A., et al. Soluble axoplasm enriched from injured CNS axons reveals the early modulation of the actin cytoskeleton. PLoS One 2012, 7.
4. Rhein V., Song X., Wiesner A., Ittner L.M., Baysang G., Meier F., et al. Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc Natl Acad Sci U S A 2009, 106:20057-20062.
5. Datta A., Park J.E., Li X., Zhang H., Ho Z.S., Heese K., et al. Phenotyping of an in vitro model of ischemic penumbra by iTRAQ-based shotgun quantitative proteomics. J Proteome Res 2010, 9:472-484.
6. Datta A., Jingru Q., Khor T.H., Teo M.T., Heese K., Sze S.K. Quantitative neuroproteomics of an in vivo rodent model of focal cerebral ischemia/reperfusion injury reveals a temporal regulation of novel pathophysiological molecular markers. J Proteome Res 2011, 10:5199-5213.
7. Dirnagl U. Bench to bedside: the quest for quality in experimental stroke research. J Cereb Blood Flow Metab 2006, 26:1465-1478.
8. Marian A.J. Modeling human disease phenotype in model organisms: "it's only a model!". Circ Res 2011, 109:356-359.
9. Lim M.D., Dickherber A., Compton C.C. Before you analyze a human specimen, think quality, variability, and bias. Anal Chem 2011, 83:8-13.
10. Pan S., Shi M., Jin J., Albin R.L., Lieberman A., Gearing M., et al. Proteomics identification of proteins in human cortex using multidimensional separations and MALDI tandem mass spectrometer. Mol Cell Proteomics 2007, 6:1818-1823.
11. Martins-de-Souza D., Gattaz W.F., Schmitt A., Rewerts C., Maccarrone G., Dias-Neto E., et al. Proteome analysis of human dorsolateral prefrontal cortex using shotgun mass spectrometry. J Sep Sci 2008, 31:3122-3126.
12. Bayés À., Van De Lagemaat L.N., Collins M.O., Croning M.D.R., Whittle I.R., Choudhary J.S., et al. Characterization of the proteome, diseases and evolution of the human postsynaptic density. Nat Neurosci 2011, 14:19-21.
13. DeGiorgis J.A., Jaffe H., Moreira J.E., Carlotti C.G., Leite J.P., Pant H.C., et al. Phosphoproteomic analysis of synaptosomes from human cerebral cortex. J Proteome Res 2005, 4:306-315.
14. Cuadrado E., Rosell A., Penalba A., Slevin M., Alvarez-Sabín J., Ortega-Aznar A., et al. Vascular MMP-9/TIMP-2 and neuronal MMP-10 up-regulation in human brain after stroke: a combined laser microdissection and protein array study. J Proteome Res 2009, 8:3191-3197.
15. Cuadrado E., Rosell A., Colomé N., Hernández-Guillamon M., García-Berrocoso T., Ribo M., et al. The proteome of human brain after ischemic stroke. J Neuropathol Exp Neurol 2010, 69:1105-1115.
16. Washburn M.P., Wolters D., Yates J.R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001, 19:242-247.
17. Akatsu H. Collaboration between Fukushimura Brain Bank, based in a private geriatric hospital and a national/international network. Brain Nerve 2010, 62:1043-1052.
18. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41:479-486.
19. Braak H., Alafuzoff I., Arzberger T., Kretzschmar H., Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006, 112:389-404.
20. Akatsu H., Takahashi M., Matsukawa N., Ishikawa Y., Kondo N., Sato T., et al. Subtype analysis of neuropathologically diagnosed patients in a Japanese geriatric hospital. J Neurol Sci 2002, 196:63-69.
21. Roman G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology 1993, 43:250-260.
22. Payabvash S., Souza L.C., Wang Y., Schaefer P.W., Furie K.L., Halpern E.F., et al. Regional ischemic vulnerability of the brain to hypoperfusion: the need for location specific computed tomography perfusion thresholds in acute stroke patients. Stroke 2011, 42:1255-1260.
23. Foley L.M., Hitchens T.K., Barbe B., Zhang F., Ho C., Rao G.R., et al. Quantitative temporal profiles of penumbra and infarction during permanent middle cerebral artery occlusion in rats. Transl Stroke Res 2010, 1:220-229.
24. Ross P.L., Huang Y.N., Marchese J.N., Williamson B., Parker K., Hattan S., et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 2004, 3:1154-1169.
25. Hao P., Qian J., Ren Y., Sze S.K. Electrostatic repulsion-hydrophilic interaction chromatography (ERLIC) versus strong cation exchange (SCX) for fractionation of iTRAQ-labeled peptides. J Proteome Res 2011, 10:5568-5574.
26. Huang D.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
27. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998, 95:14863-14868.
28. Korolainen M.A., Nyman T.A., Aittokallio T., Pirttilä T. An update on clinical proteomics in Alzheimer's research. J Neurochem 2010, 112:1386-1414.
29. Del Gaizo V., MacKenzie J.A., Payne R.M. Targeting proteins to mitochondria using TAT. Mol Genet Metab 2003, 80:170-180.
30. Murray I.V., Proza J.F., Sohrabji F., Lawler J.M. Vascular and metabolic dysfunction in Alzheimer's disease: a review. Exp Biol Med (Maywood) 2011, 236:772-782.
31. Arthur C.R., Morton S.L., Dunham L.D., Keeney P.M., Bennett J.P. Parkinson's disease brain mitochondria have impaired respirasome assembly, age-related increases in distribution of oxidative damage to mtDNA and no differences in heteroplasmic mtDNA mutation abundance. Mol Neurodegener 2009, 4:37.
32. Filiou M.D., Turck C.W., Martins-De-Souza D. Quantitative proteomics for investigating psychiatric disorders. Proteomics Clin Appl 2011, 5:38-49.
33. Napolioni V., Persico A.M., Porcelli V., Palmieri L. The mitochondrial aspartate/glutamate carrier AGC1 and calcium homeostasis: physiological links and abnormalities in autism. Mol Neurobiol 2011, 44:83-92.
34. Berkich D.A., Ola M.S., Cole J., Sweatt A.J., Hutson S.M., LaNoue K.F. Mitochondrial transport proteins of the brain. J Neurosci Res 2007, 85:3367-3377.
35. Kabe Y., Ohmori M., Shinouchi K., Tsuboi Y., Hirao S., Azuma M., et al. Porphyrin accumulation in mitochondria is mediated by 2-oxoglutarate carrier. J Biol Chem 2006, 281:31729-31735.
36. Mizui T., Kinouchi H., Chan P.H. Depletion of brain glutathione by buthionine sulfoximine enhances cerebral ischemic injury in rats. Am J Physiol 1992, 262:H313-H317.
37. Gabryel B., Malecki A. Ebselen attenuates oxidative stress in ischemic astrocytes depleted of glutathione. Comparison with glutathione precursors. Pharmacol Rep 2006, 58:381-392.
38. Lash L.H. Mitochondrial glutathione transport: physiological, pathological and toxicological implications. Chem Biol Interact 2006, 163:54-67.
39. Sugden M.C., Holness M.J. Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs. Am J Physiol Endocrinol Metab 2003, 284:E855-E862.
40. Head R.A., Brown R.M., Zolkipli Z., Shahdadpuri R., King M.D., Clayton P.T., et al. Clinical and genetic spectrum of pyruvate dehydrogenase deficiency: dihydrolipoamide acetyltransferase (E2) deficiency. Ann Neurol 2005, 58:234-241.
41. Caplan L.R. Ataxia in patients with brain infarcts and hemorrhages. Handb Clin Neurol 2012, 103:147-160.
42. Selim M.H., Ratan R.R. The role of iron neurotoxicity in ischemic stroke. Ageing Res Rev 2004, 3:345-353.
43. Schonberg D.L., Goldstein E.Z., Sahinkaya F.R., Wei P., Popovich P.G., McTigue D.M. Ferritin stimulates oligodendrocyte genesis in the adult spinal cord and can be transferred from macrophages to NG2 cells in vivo. J Neurosci 2012, 32:5374-5384.
44. Jiang S.X., Slinn J., Aylsworth A., Hou S.T. Vimentin participates in microglia activation and neurotoxicity in cerebral ischemia. J Neurochem 2012, 122:764-774.
45. Millan M., Sobrino T., Arenillas J.F., Rodriguez-Yanez M., Garcia M., Nombela F., et al. Biological signatures of brain damage associated with high serum ferritin levels in patients with acute ischemic stroke and thrombolytic treatment. Dis Markers 2008, 25:181-188.
46. Stan A.D., Ghose S., Gao X.M., Roberts R.C., Lewis-Amezcua K., Hatanpaa K.J., et al. Human postmortem tissue: what quality markers matter?. Brain Res 2006, 1123:1-11.
47. Hynd M.R., Lewohl J.M., Scott H.L., Dodd P.R. Biochemical and molecular studies using human autopsy brain tissue. J Neurochem 2003, 85:543-562.